Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine

International Journal of Neuroscience

Volumn 112, Issue 10, 2002, Pages 1173-1181

  Shimodozono, Megumi ^a   Kawahira, Kazumi ^a   Kamishita, Tomoyuki ^a   Ogata, Atsuko ^a   Tohgo, Shin Ichi ^a   Tanaka, Nobuyuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Antidepressant; Central pain; Depression; SSRI; Thalamic pain; VAS

Indexed keywords

FLUVOXAMINE; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LIMBIC SYSTEM; MALE; METABOLISM; MIDDLE AGED; NERVE TRACT; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; THALAMUS; VISION;

CEREBROVASCULAR ACCIDENT; CORPUS STRIATUM; DOUBLE-BLIND METHOD; FEMALE; FLUVOXAMINE; HUMANS; LIMBIC SYSTEM; MALE; MIDDLE AGED; NEURAL PATHWAYS; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; THALAMUS; VISUAL PERCEPTION;

EID: 0036804470     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450290026139     Document Type: Article

References (19)

1. Andersen, G., Vestergaard, K., Ingeman-Nielsen, M., & Jensen, T. S. (1995). Incidence of central post-stroke pain. Pain. 61, 187-193.
2. Casey, K. L. (Ed.) (1991). The central pain syndromes. In K. L. Casey (Ed.), Pain and Central Nervous System Disease. New York: Raven Press.
3. Cooper, J. R., Bloom, F. E., & Roth, R. H. (1982). The Biochemical Basis of Neuropharmacology (p. 223). New York: Oxford.
4. Coquoz, D., Pharm, D, Porchet, H. C., & Dayer, P. (1993). Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: A study in healthy volunteers. Clinical Pharmacology and Therapeutics, 54, 339-344.
5. Dam, M., Tonin, P., Boni, A. D., Pizzolato, G., Casson, S., Ermani, M., Freo, U., Prion, L., & Battistin, L. (1996). Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke, 27, 1211-1214.
6. Dejerine, J., & Roussy, G. (1906). La syndrome thalamique. Revue Neurologique, 14, 521-532.
7. Egbunike, I. G., & Chaffee, B. J. (1990). Antidepressants in the management of chronic pain syndromes. Pharmacotherapy, 10, 262-270.
8. Goddard, M. J., Dean, B. J., & King, J. C. (1994). Pain rehabilitation. 1. Basic science, acute pain, and neuropathic pain. Archives of Physical Medicine and Rehabilitation, 75, S4-S8.
9. Gonzales, G. R. (1995). Central pain: Diagnosis and treatment strategies. Neurology, 45(suppl 9), S11-S16.
10. Jensen, T. S., & Lenz, F. A. (1995). Central post-stroke pain: A challenge for the scientist and the clinician. Pain, 61, 161-164.
11. Jones, S. L., & Gebhart, G. F. (1987). Spinal pathways mediating tonic, coeruleospinal, and raphe-spinal descending inhibition in the rat. Journal of Neurophysiology, 58, 138-159.
12. Jung, A. C., Staiger, T., & Sullivan, M. (1997). The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. Journal of General Internal Medicine, 12, 384-389.
13. Leijon, G., & Boivie, J. (1989). Central post-stroke pain: A controlled trial of amitriptyline and carbamazepine. Pain, 36, 27-36.
14. Llewelyn, M. B., Azami, J., & Roberts, M. H. (1984). The effect of modification of 5-hydroxytryptamine function in nucleus raphe magnus on nociceptive threshold. Brain Research, 306, 165-170.
15. Marazziti, D., Castrogiovanni, P., Rossi, A., Rosa, C., Ghione, S., Di Muro A., Panattoni, E., & Cassano, G. B. (1998). Pain threshold is reduced in depression. International Journal of Neuropsychopharmacology, 1, 45-48.
16. Mourilhe, P., & Stokes, P. E. (1998). Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression. Drug Safety, 18, 57-82.
17. Nurmikko, T. J. (2000). Mechanisms of central pain. Clinical Journal of Pain, 16, 21-25.
18. Schreiber, S., Backer, M. M., Yanai, J., & Pick, C. G. (1996). The antinociceptive effect of fluvoxamine. European Neuropsychopharmacology, 4, 281-284.
19. Smith, A. J. (1998). The analgesic effects of selective serotonin reuptake inhibitors. Journal of Psychopharmacology, 12, 407-413.